<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Life Sciences &amp; Health Care Archive | Haslinger / Nagele Rechtsanwälte</title>
	<atom:link href="https://www.haslinger-nagele.com/en/category/sectors/life-sciences-health-care/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.haslinger-nagele.com/en/category/sectors/life-sciences-health-care/</link>
	<description></description>
	<lastBuildDate>Tue, 06 Oct 2026 10:09:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>
	<item>
		<title>Comprehensive commentary on the Digital Services Act (DSA)</title>
		<link>https://www.haslinger-nagele.com/en/__trashed-3/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Tue, 22 Sep 2026 09:02:16 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence & Digitalization]]></category>
		<category><![CDATA[Data Protection, Telecommunications & Digitization]]></category>
		<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Technology & Digitization]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/?p=25484</guid>

					<description><![CDATA[<p>Mathis Fister and Markus Gaderer provided commentary on no fewer than seven articles of the DSA for the newly published comprehensive commentary.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/__trashed-3/">Comprehensive commentary on the Digital Services Act (DSA)</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Handbook Medical Law</title>
		<link>https://www.haslinger-nagele.com/en/handbuch-medizinrecht/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Wed, 27 May 2026 13:11:58 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/handbuch-medizinrecht/</guid>

					<description><![CDATA[<p>Dominique Korbel has written a chapter on medical genetic engineering law in the new Handbook of Medical Law.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/handbuch-medizinrecht/">Handbook Medical Law</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Telemedicine from a cross-border perspective</title>
		<link>https://www.haslinger-nagele.com/en/telemedizin-grenzueberschreitend-betrachtet/</link>
		
		<dc:creator><![CDATA[Tanja Kobler]]></dc:creator>
		<pubDate>Tue, 21 Apr 2026 09:30:45 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/telemedizin-grenzueberschreitend-betrachtet/</guid>

					<description><![CDATA[<p>In the latest issue of the Journal of Medical and Health Law, Gisela Ernst and Thomas Riesz examine the recent ruling by the European Court of Justice.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/telemedizin-grenzueberschreitend-betrachtet/">Telemedicine from a cross-border perspective</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Outlook for 2026</title>
		<link>https://www.haslinger-nagele.com/en/ausblick-auf-2026/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Wed, 11 Feb 2026 10:54:12 +0000</pubDate>
				<category><![CDATA[360° Renewable Energy]]></category>
		<category><![CDATA[Artificial Intelligence & Digitalization]]></category>
		<category><![CDATA[Commercial & Corporate]]></category>
		<category><![CDATA[Criminal Defense & White Collar Crime]]></category>
		<category><![CDATA[Data Protection, Telecommunications & Digitization]]></category>
		<category><![CDATA[Energy Industry]]></category>
		<category><![CDATA[Environmental & Technology]]></category>
		<category><![CDATA[ESG and Sustainability]]></category>
		<category><![CDATA[Insolvency & Restructuring]]></category>
		<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Public Economic and Constitutional Law]]></category>
		<category><![CDATA[Public Procurement]]></category>
		<category><![CDATA[Start-ups]]></category>
		<category><![CDATA[Technology & Digitization]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/?p=23325</guid>

					<description><![CDATA[<p>The lawyers at Haslinger / Nagele look to the future and provide an outlook on what legal changes 2026 could and will bring.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/ausblick-auf-2026/">Outlook for 2026</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>(Un)social egg freezing</title>
		<link>https://www.haslinger-nagele.com/en/unsocial-egg-freezing/</link>
		
		<dc:creator><![CDATA[Empfang]]></dc:creator>
		<pubDate>Tue, 27 Jan 2026 07:47:37 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/unsocial-egg-freezing/</guid>

					<description><![CDATA[<p>Johanna Fischer-Proier and Gisela Ernst take a look at the latest developments surrounding the Constitutional Court ruling on social egg freezing.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/unsocial-egg-freezing/">(Un)social egg freezing</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Die Presse: telemedicine before the ECJ – the ruling</title>
		<link>https://www.haslinger-nagele.com/en/die-presse-telemedizin-vor-dem-eugh-das-urteil/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Wed, 15 Oct 2025 11:42:06 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/die-presse-telemedizin-vor-dem-eugh-das-urteil/</guid>

					<description><![CDATA[<p>The Life Sciences Practice Group explains the groundbreaking ruling of the European Court of Justice in a guest article. </p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/die-presse-telemedizin-vor-dem-eugh-das-urteil/">Die Presse: telemedicine before the ECJ – the ruling</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>&#8220;Weight loss injections&#8221; covered by health insurance? The legal situation in Austria</title>
		<link>https://www.haslinger-nagele.com/en/abnehmspritzen-auf-kosten-der-krankenkasse-die-rechtslage-in-oesterreich/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Mon, 11 Aug 2025 11:53:10 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/abnehmspritzen-auf-kosten-der-krankenkasse-die-rechtslage-in-oesterreich/</guid>

					<description><![CDATA[<p>Gisela Ernst and Karl Stöger discuss the “multilayered” legal situation in Gesundheitsrecht.blog. </p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/abnehmspritzen-auf-kosten-der-krankenkasse-die-rechtslage-in-oesterreich/">&#8220;Weight loss injections&#8221; covered by health insurance? The legal situation in Austria</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Cross-border telemedicine before the ECJ – country-of-origin or country-of-destination principle?</title>
		<link>https://www.haslinger-nagele.com/en/grenzueberschreitende-telemedizin-vor-dem-eugh-herkunftslandprinzip-oder-bestimmungslandprinzip/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Wed, 14 May 2025 09:40:09 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/news/grenzueberschreitende-telemedizin-vor-dem-eugh-herkunftslandprinzip-oder-bestimmungslandprinzip/</guid>

					<description><![CDATA[<p>Gisela Ernst and Dominique Korbel provide an overview of the legal classification of telemedicine at national and EU level.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/grenzueberschreitende-telemedizin-vor-dem-eugh-herkunftslandprinzip-oder-bestimmungslandprinzip/">Cross-border telemedicine before the ECJ – country-of-origin or country-of-destination principle?</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Merger control notification requirements – a question of the right timing?</title>
		<link>https://www.haslinger-nagele.com/en/fusionskontrollrechtliche-anmeldepflichten-eine-frage-des-richtigen-timings/</link>
		
		<dc:creator><![CDATA[Tanja Kobler]]></dc:creator>
		<pubDate>Tue, 06 May 2025 11:07:40 +0000</pubDate>
				<category><![CDATA[Antitrust, Competition & State Aid]]></category>
		<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/news/fusionskontrollrechtliche-anmeldepflichten-eine-frage-des-richtigen-timings/</guid>

					<description><![CDATA[<p>Florian Krumbiegel provides an overview of the merger control notification requirements for the acquisition of innovative pharmaceutical companies.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/fusionskontrollrechtliche-anmeldepflichten-eine-frage-des-richtigen-timings/">Merger control notification requirements – a question of the right timing?</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>The EHDS – new rules for health data: overview and outlook</title>
		<link>https://www.haslinger-nagele.com/en/der-ehds-neue-regeln-fuer-gesundheitsdaten-ueberblick-und-ausblick/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Wed, 02 Apr 2025 09:25:45 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/news/der-ehds-neue-regeln-fuer-gesundheitsdaten-ueberblick-und-ausblick/</guid>

					<description><![CDATA[<p>Dominique Korbel and Gisela Ernst take a look at the EHDS Regulation and the challenges posed by the new regulations.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/der-ehds-neue-regeln-fuer-gesundheitsdaten-ueberblick-und-ausblick/">The EHDS – new rules for health data: overview and outlook</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>The EU pharmaceutical package – overview and outlook</title>
		<link>https://www.haslinger-nagele.com/en/das-eu-pharmapaket-ueberblick-und-ausblick/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Mon, 27 Jan 2025 15:35:42 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/news/das-eu-pharmapaket-ueberblick-und-ausblick/</guid>

					<description><![CDATA[<p>In this article, Gisela Ernst sheds light on the EU pharma package with an overview and outlook.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/das-eu-pharmapaket-ueberblick-und-ausblick/">The EU pharmaceutical package – overview and outlook</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Outlook for 2025</title>
		<link>https://www.haslinger-nagele.com/en/ausblick-auf-2025/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Mon, 27 Jan 2025 15:35:37 +0000</pubDate>
				<category><![CDATA[360° Renewable Energy]]></category>
		<category><![CDATA[Commercial & Corporate]]></category>
		<category><![CDATA[Criminal Defense & White Collar Crime]]></category>
		<category><![CDATA[Data Protection, Telecommunications & Digitization]]></category>
		<category><![CDATA[Energy Industry]]></category>
		<category><![CDATA[Environmental & Technology]]></category>
		<category><![CDATA[ESG and Sustainability]]></category>
		<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Public Economic and Constitutional Law]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/news/ausblick-auf-2025/</guid>

					<description><![CDATA[<p>Much is uncertain, some is possible. The lawyers at Haslinger / Nagele look to the future and provide an outlook on the legal innovations that 2025 could bring.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/ausblick-auf-2025/">Outlook for 2025</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Gender data gap in medicine: a legal perspective</title>
		<link>https://www.haslinger-nagele.com/en/gender-data-gap-in-der-medizin-eine-rechtliche-perspektive/</link>
		
		<dc:creator><![CDATA[Eva Sattlecker]]></dc:creator>
		<pubDate>Wed, 15 Jan 2025 10:26:58 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/news/gender-data-gap-in-der-medizin-eine-rechtliche-perspektive/</guid>

					<description><![CDATA[<p>In her guest article for the University of Vienna's science magazine “Rudolphina”, Gisela Ernst sheds light on the legal dimensions of the “gender data gap” in medical research.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/gender-data-gap-in-der-medizin-eine-rechtliche-perspektive/">Gender data gap in medicine: a legal perspective</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>The app on prescription – &#8220;DiGA&#8221; in Austria?</title>
		<link>https://www.haslinger-nagele.com/en/the-app-on-prescription-diga-in-austria/</link>
		
		<dc:creator><![CDATA[Oliver Buchberger]]></dc:creator>
		<pubDate>Thu, 14 Nov 2024 11:11:07 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/?p=18556</guid>

					<description><![CDATA[<p>Gisela Ernst gives an overview of the reimbursement of digital health applications by social insurance, but the road ahead is not yet fully paved.</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/the-app-on-prescription-diga-in-austria/">The app on prescription – &#8220;DiGA&#8221; in Austria?</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Current developments in the use of medicinal products in hospitals</title>
		<link>https://www.haslinger-nagele.com/en/current-developments-in-the-use-of-medicinal-products-in-hospitals/</link>
		
		<dc:creator><![CDATA[Tanja Kobler]]></dc:creator>
		<pubDate>Mon, 01 Jul 2024 07:01:00 +0000</pubDate>
				<category><![CDATA[Life Sciences & Health Care]]></category>
		<category><![CDATA[Life Sciences & Health Law]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.haslinger-nagele.com/?p=17664</guid>

					<description><![CDATA[<p>Who pays creates? - Not quite. A brief insight into the depths of intramural drug supply</p>
<p>Der Beitrag <a href="https://www.haslinger-nagele.com/en/current-developments-in-the-use-of-medicinal-products-in-hospitals/">Current developments in the use of medicinal products in hospitals</a> erschien zuerst auf <a href="https://www.haslinger-nagele.com/en/">Haslinger / Nagele Rechtsanwälte</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
